Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias.
Marti M, Rodi D, Li Q, Guerrini R, Fasano S, Morella I, Tozzi A, Brambilla R, Calabresi P, Simonato M, Bezard E, Morari M. Marti M, et al. Among authors: morari m. J Neurosci. 2012 Nov 14;32(46):16106-19. doi: 10.1523/JNEUROSCI.6408-11.2012. J Neurosci. 2012. PMID: 23152595 Free PMC article.
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease.
Bastide MF, Meissner WG, Picconi B, Fasano S, Fernagut PO, Feyder M, Francardo V, Alcacer C, Ding Y, Brambilla R, Fisone G, Jon Stoessl A, Bourdenx M, Engeln M, Navailles S, De Deurwaerdère P, Ko WK, Simola N, Morelli M, Groc L, Rodriguez MC, Gurevich EV, Quik M, Morari M, Mellone M, Gardoni F, Tronci E, Guehl D, Tison F, Crossman AR, Kang UJ, Steece-Collier K, Fox S, Carta M, Angela Cenci M, Bézard E. Bastide MF, et al. Among authors: morari m. Prog Neurobiol. 2015 Sep;132:96-168. doi: 10.1016/j.pneurobio.2015.07.002. Epub 2015 Jul 21. Prog Neurobiol. 2015. PMID: 26209473 Review.
Managing Parkinson's disease: moving ON with NOP.
Mercatelli D, Bezard E, Eleopra R, Zaveri NT, Morari M. Mercatelli D, et al. Among authors: morari m. Br J Pharmacol. 2020 Jan;177(1):28-47. doi: 10.1111/bph.14893. Epub 2020 Jan 3. Br J Pharmacol. 2020. PMID: 31648371 Free PMC article. Review.
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates.
Bourdenx M, Nioche A, Dovero S, Arotcarena ML, Camus S, Porras G, Thiolat ML, Rougier NP, Prigent A, Aubert P, Bohic S, Sandt C, Laferrière F, Doudnikoff E, Kruse N, Mollenhauer B, Novello S, Morari M, Leste-Lasserre T, Damas IT, Goillandeau M, Perier C, Estrada C, Garcia-Carrillo N, Recasens A, Vaikath NN, El-Agnaf OMA, Herrero MT, Derkinderen P, Vila M, Obeso JA, Dehay B, Bezard E. Bourdenx M, et al. Among authors: morari m. Sci Adv. 2020 May 13;6(20):eaaz9165. doi: 10.1126/sciadv.aaz9165. eCollection 2020 May. Sci Adv. 2020. PMID: 32426502 Free PMC article.
LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation.
Pischedda F, Cirnaru MD, Ponzoni L, Sandre M, Biosa A, Carrion MP, Marin O, Morari M, Pan L, Greggio E, Bandopadhyay R, Sala M, Piccoli G. Pischedda F, et al. Among authors: morari m. Brain. 2021 Jun 22;144(5):1509-1525. doi: 10.1093/brain/awab073. Brain. 2021. PMID: 33876242
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity.
Novello S, Mercatelli D, Albanese F, Domenicale C, Brugnoli A, D'Aversa E, Vantaggiato S, Dovero S, Murtaj V, Presotto L, Borgatti M, Shimshek DR, Bezard E, Moresco RM, Belloli S, Morari M. Novello S, et al. Among authors: morari m. Neurobiol Dis. 2022 Jan;162:105579. doi: 10.1016/j.nbd.2021.105579. Epub 2021 Dec 3. Neurobiol Dis. 2022. PMID: 34871735 Free article.
172 results